WO2007136553A3 - Bacterial strains, compositions including same and probiotic use thereof - Google Patents

Bacterial strains, compositions including same and probiotic use thereof Download PDF

Info

Publication number
WO2007136553A3
WO2007136553A3 PCT/US2007/011200 US2007011200W WO2007136553A3 WO 2007136553 A3 WO2007136553 A3 WO 2007136553A3 US 2007011200 W US2007011200 W US 2007011200W WO 2007136553 A3 WO2007136553 A3 WO 2007136553A3
Authority
WO
WIPO (PCT)
Prior art keywords
bacterial strains
compositions including
including same
probiotic use
probiotic
Prior art date
Application number
PCT/US2007/011200
Other languages
French (fr)
Other versions
WO2007136553A2 (en
Inventor
Andrew K Benson
Robert A Hoerr
Eileen F Bostwick
Original Assignee
Bio Balance Corp
Andrew K Benson
Robert A Hoerr
Eileen F Bostwick
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bio Balance Corp, Andrew K Benson, Robert A Hoerr, Eileen F Bostwick filed Critical Bio Balance Corp
Priority to CA002652558A priority Critical patent/CA2652558A1/en
Priority to EP07794688A priority patent/EP2035544A2/en
Priority to JP2009510981A priority patent/JP2009537138A/en
Publication of WO2007136553A2 publication Critical patent/WO2007136553A2/en
Publication of WO2007136553A3 publication Critical patent/WO2007136553A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/19—Dairy proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/185—Escherichia
    • C12R2001/19—Escherichia coli

Abstract

A biologically pure culture of an E. coli M17 bacterial strain exhibiting nalidixic acid resistance is provided. Also provided are methods of using this bacterial strains and compositions containing same.
PCT/US2007/011200 2006-05-18 2007-05-09 Bacterial strains, compositions including same and probiotic use thereof WO2007136553A2 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
CA002652558A CA2652558A1 (en) 2006-05-18 2007-05-09 Bacterial strains, compositions including same and probiotic use thereof
EP07794688A EP2035544A2 (en) 2006-05-18 2007-05-09 Bacterial strains, compositions including same and probiotic use thereof
JP2009510981A JP2009537138A (en) 2006-05-18 2007-05-09 Bacterial strain, composition containing this bacterial strain and its probiotic use

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US80109806P 2006-05-18 2006-05-18
US60/801,098 2006-05-18

Publications (2)

Publication Number Publication Date
WO2007136553A2 WO2007136553A2 (en) 2007-11-29
WO2007136553A3 true WO2007136553A3 (en) 2008-01-31

Family

ID=38647934

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2007/011200 WO2007136553A2 (en) 2006-05-18 2007-05-09 Bacterial strains, compositions including same and probiotic use thereof

Country Status (4)

Country Link
EP (1) EP2035544A2 (en)
JP (1) JP2009537138A (en)
CA (1) CA2652558A1 (en)
WO (1) WO2007136553A2 (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8968721B2 (en) 2005-12-28 2015-03-03 Advanced Bionutrition Corporation Delivery vehicle for probiotic bacteria comprising a dry matrix of polysaccharides, saccharides and polyols in a glass form and methods of making same
US9480276B2 (en) 2006-12-18 2016-11-01 Advanced Bionutrition Corporation Dry food product containing live probiotic
US9504275B2 (en) 2010-08-13 2016-11-29 Advanced Bionutrition Corporation Dry storage stabilizing composition for biological materials
US9504750B2 (en) 2010-01-28 2016-11-29 Advanced Bionutrition Corporation Stabilizing composition for biological materials

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1715755T3 (en) 2004-02-03 2015-03-09 Prevtec Microbia Inc Use of live bacteria to promote growth in animals
US8097245B2 (en) 2005-12-28 2012-01-17 Advanced Bionutrition Corporation Delivery vehicle for probiotic bacteria comprising a dry matrix of polysaccharides, saccharides and polyols in a glass form and methods of making same
CA2756883C (en) 2009-03-27 2018-01-09 Advanced Bionutrition Corp. Microparticulated vaccines for the oral or nasal vaccination and boostering of animals including fish
GB0922467D0 (en) * 2009-04-24 2010-02-03 Danisco Feed supplement
MX2011012586A (en) * 2009-05-26 2012-03-26 Advanced Bionutrition Corp Stable dry powder composition comprising biologically active microorganisms and/or bioactive materials and methods of making.
RU2535869C2 (en) 2010-01-28 2014-12-20 Эдванст Бионутришн Корпорейшн Dry glass-like composition for stabilisation and protection of biologically active material, and method for its obtaining
AU2011253984A1 (en) 2010-12-07 2012-06-28 Biobalance Llc Method For Identifying E. Coli M-17
CN102653779B (en) * 2011-03-04 2014-02-19 北京科润三联生物技术有限责任公司 Novel preparation method of recombinant antibacterial polypeptide medicament
KR101794242B1 (en) * 2011-06-07 2017-11-07 임병갑 Sustained-release oral liquid formulations
CN103748211B (en) * 2011-07-13 2016-05-18 食品安全测试系统公司 Be used for listerial culture medium and cultural method and detect listerial method
CN103131724B (en) * 2011-11-25 2015-02-25 畿晋庆三联（北京）生物技术有限公司 Efficient engineering bacteria recombinant protein expression method and applications thereof
EP3628161B1 (en) * 2012-11-23 2023-04-05 Seres Therapeutics, Inc. Synergistic bacterial compositions and methods of production and use thereof
US8906668B2 (en) 2012-11-23 2014-12-09 Seres Health, Inc. Synergistic bacterial compositions and methods of production and use thereof
EP3904502A3 (en) 2013-02-04 2022-02-23 Seres Therapeutics, Inc. Compositions and methods
CN110917220A (en) 2013-02-04 2020-03-27 赛里斯治疗公司 Therapeutic compositions and methods of use thereof
AU2014232370B2 (en) 2013-03-15 2018-11-01 Seres Therapeutics, Inc. Network-based microbial compositions and methods
RU2722482C2 (en) 2013-11-25 2020-06-01 Серес Терапеутикс, Инк. Synergistic bacterial compositions and methods for preparing and using them
US9956282B2 (en) 2013-12-16 2018-05-01 Seres Therapeutics, Inc. Bacterial compositions and methods of use thereof for treatment of immune system disorders
AU2016297986B8 (en) 2015-07-29 2020-06-11 Advanced Bionutrition Corp. Stable dry probiotic compositions for special dietary uses
CN111212655A (en) 2017-08-14 2020-05-29 赛里斯治疗公司 Compositions and methods for treating cholestatic diseases
JP7252606B2 (en) * 2019-03-25 2023-04-05 国立研究開発法人農業・食品産業技術総合研究機構 Lactic acid bacteria detection primer set and detection method using the primer set

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000075284A1 (en) * 1999-06-03 2000-12-14 The Bio Balance Corporation A bacterial strain, processed plant extracts and probiotic compositions for human and veterinary use

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000075284A1 (en) * 1999-06-03 2000-12-14 The Bio Balance Corporation A bacterial strain, processed plant extracts and probiotic compositions for human and veterinary use

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
FITZPATRICK LEO R ET AL: "Effects of the probiotic E-coli strain M-17 on chronic dextran sulfate sodium-induced colitis in mice", GASTROENTEROLOGY, vol. 130, no. 4, Suppl. 2, April 2006 (2006-04-01), & DIGESTIVE DISEASE WEEK MEETING/107TH ANNUAL MEETING OF THE AMERICAN-GASTROENTEROLOGICAL-ASSOCIATION; LOS ANGELES, CA, USA; MAY 19 24, 2006, pages A313, XP009092064, ISSN: 0016-5085 *
KASTNER ET AL: "Antibiotic susceptibility patterns and resistance genes of starter cultures and probiotic bacteria used in food", SYSTEMATIC AND APPLIED MICROBIOLOGY, XX, XX, vol. 29, no. 2, 1 March 2006 (2006-03-01), pages 145 - 155, XP005276214, ISSN: 0723-2020 *
MATHUR ET AL: "Antibiotic resistance in food lactic acid bacteria-a review", INTERNATIONAL JOURNAL OF FOOD MICROBIOLOGY, ELSEVIER SCIENCE PUBLISHERS, AMSTERDAM, NL, vol. 105, no. 3, 15 December 2005 (2005-12-15), pages 281 - 295, XP005186597, ISSN: 0168-1605 *
VILA JORDI ET AL: "Detection of mutations in parC in quinolone-resistant clinical isolates of Escherichia coli", ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, vol. 40, no. 2, 1996, pages 491 - 493, XP002458309, ISSN: 0066-4804 *
VILA JORDI ET AL: "Quinolone resistance in enterotoxigenic Escherichia coli causing diarrhea in travelers to India in comparison with other geographical areas", ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, vol. 44, no. 6, June 2000 (2000-06-01), pages 1731 - 1733, XP002458310, ISSN: 0066-4804 *

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8968721B2 (en) 2005-12-28 2015-03-03 Advanced Bionutrition Corporation Delivery vehicle for probiotic bacteria comprising a dry matrix of polysaccharides, saccharides and polyols in a glass form and methods of making same
US9480276B2 (en) 2006-12-18 2016-11-01 Advanced Bionutrition Corporation Dry food product containing live probiotic
US9504750B2 (en) 2010-01-28 2016-11-29 Advanced Bionutrition Corporation Stabilizing composition for biological materials
US9504275B2 (en) 2010-08-13 2016-11-29 Advanced Bionutrition Corporation Dry storage stabilizing composition for biological materials

Also Published As

Publication number Publication date
EP2035544A2 (en) 2009-03-18
WO2007136553A2 (en) 2007-11-29
CA2652558A1 (en) 2007-11-29
JP2009537138A (en) 2009-10-29

Similar Documents

Publication Publication Date Title
WO2007136553A3 (en) Bacterial strains, compositions including same and probiotic use thereof
EP1812023B8 (en) Lactic acid bacteria as probiotic strains and compositions containing same
WO2006031424A3 (en) Mutant e. coli strain with increased succinic acid production
WO2006020663A3 (en) Aerobic succinate production in bacteria
RU2010146956A (en) NEW LACTOBACILLUS PARACASEI SUBSPECIES PARACASEI STRAIN WITH ANTIMICROBIAL AND IMMUNOMODULATING PROPERTIES
WO2008125365A8 (en) Microbial population analysis
PL1673100T3 (en) Folic acid producing bifidobacterium bacterial strains, formulations and use thereof
UA101316C2 (en) Normal;heading 1;heading 2;heading 3;USE OF SELECTED LACTIC ACID BACTERIA FOR REDUCING ATHEROSCLEROSIS
EP2543726A8 (en) Reduced genome E. coli
SE0402406D0 (en) Probiotic lactobacillus strains for improved vaginal health
SI1931363T1 (en) Treatment of ibd using both probiotic bacteria and fermented cereal as treatment effectors
WO2007144770A3 (en) Bacterium
UA46234U (en) Composition of ingredients of bread kvass
HK1134686A1 (en) Metabolically active micro organisms and methods for their production
IL173692A0 (en) Bacterial strains, compositions including same and probiotic use thereof
WO2010085795A3 (en) Novel pasteuria strain
EP1946760A4 (en) Composition for improving intestinal flora
EP2896695A3 (en) Transformation plasmid
ATE547008T1 (en) FERULATE ESTERASE PRODUCING STRAINS AND METHODS OF USE THEREOF
DK2062968T3 (en) BACKGROUND STREAMS WITH ANTI-ALLERGIC ACTIVITY, AND BEVERAGES, FOOD AND ANTI-ALLERGY PRODUCTS INCLUDING CELLS
RU2010142489A (en) STRAIN LACTOBACILLUS RHAMNOSUS
WO2006060332A3 (en) Electroporation of mycobacterium and overexpression of antigens in mycobacteria
WO2009066681A1 (en) Lactic acid bacterium-containing preparation
WO2010142055A3 (en) Composition for producing a fungicide and a biological bactericide
WO2006119780A3 (en) New antibiotic-sensitive lactic acid bacteria strains

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07794688

Country of ref document: EP

Kind code of ref document: A2

WWE Wipo information: entry into national phase

Ref document number: 2652558

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2009510981

Country of ref document: JP

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2007794688

Country of ref document: EP